First Trust Germany AlphaDEX Fund (FGM) seeks to track the NASDAQ AlphaDEX Germany Index, which selects and weights German stocks based on fundamental growth and value factors rather than market capitalization. This country-specific equity ETF provides targeted exposure to approximately 30-40 German companies chosen for their superior fundamental characteristics.
How It Works
FGM uses a rules-based, fundamentally-weighted approach that screens German stocks using growth factors (sales growth, one-year earnings growth) and value factors (book value-to-price, cash flow-to-price). Selected stocks are equally weighted within growth and value baskets, then combined with 50% allocation to each style. The fund rebalances semi-annually in March and September to maintain factor exposure and equal weighting discipline, creating a concentrated portfolio of German equities.
Key Features
- AlphaDEX methodology targets German stocks with superior fundamental metrics, potentially outperforming market-cap weighted German indexes during stock-picking favorable periods
- Concentrated approach with 30-40 holdings provides focused exposure to German market leaders rather than broad diversification
- Semi-annual rebalancing captures factor momentum while avoiding excessive turnover costs typical of monthly rebalancing strategies
Risks
- This ETF can lose significant value during German economic downturns or European financial crises, as single-country exposure eliminates geographic diversification benefits
- Factor-based selection may underperform during periods when growth and value factors fall out of favor with German investors
- Currency risk exists for U.S. investors as euro weakness against the dollar reduces returns even if German stocks perform well
Who Should Own This
Best suited as a satellite holding (5-15% of international allocation) for investors with 3+ year time horizons seeking targeted German market exposure. High risk tolerance required due to single-country concentration and factor volatility. Appropriate for tactical allocation during European recovery periods or as part of a broader developed international equity strategy.